Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Color Diagnostics, |
RCV000584305 | SCV000690461 | likely benign | Hereditary cancer-predisposing syndrome | 2016-05-22 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001712596 | SCV000716132 | likely benign | not provided | 2021-11-04 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV001142202 | SCV001302615 | uncertain significance | Lynch syndrome 5 | 2018-01-13 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. |
Invitae | RCV002061863 | SCV002407234 | benign | Hereditary nonpolyposis colorectal neoplasms | 2023-09-30 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000584305 | SCV002536334 | likely benign | Hereditary cancer-predisposing syndrome | 2021-11-29 | criteria provided, single submitter | curation | |
All of Us Research Program, |
RCV004002356 | SCV004815069 | likely benign | Lynch syndrome | 2023-03-04 | criteria provided, single submitter | clinical testing | |
Department of Pathology and Laboratory Medicine, |
RCV001357031 | SCV001552356 | likely benign | Malignant tumor of breast | no assertion criteria provided | clinical testing | The MSH6 c.628-13C>G variant was not identified in the literature nor was it identified in the GeneInsight-COGR, Cosmic, UMD-LSDB, Zhejiang University, Mismatch Repair Genes Variant Database, MMR Gene Unclassified Variants Database, or Insight Hereditary Tumors databases. The variant was identified in dbSNP (ID: rs538280815), ClinVar (classified as likely benign by Color Genomics and GeneDx), and Clinvitae databases. The variant was identified in control databases in 25 of 237946 chromosomes at a frequency of 0.0001 (Genome Aggregation Database Feb 27, 2017). The variant was identified in South Asian population in 25 of 30692 chromosomes (freq: 0.001), while the variant was not observed in the African, Other, Latino, European, Ashkenazi Jewish, East Asian, or Finnish populations. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer, HumanSpliceFinder) do not predict a difference in splicing. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time although we would lean towards a more benign role for this variant. This variant is classified as likely benign. |